CN104427982B - 治疗炎性和免疫障碍的组合物 - Google Patents

治疗炎性和免疫障碍的组合物 Download PDF

Info

Publication number
CN104427982B
CN104427982B CN201380028968.9A CN201380028968A CN104427982B CN 104427982 B CN104427982 B CN 104427982B CN 201380028968 A CN201380028968 A CN 201380028968A CN 104427982 B CN104427982 B CN 104427982B
Authority
CN
China
Prior art keywords
glucosamine
inflammatory
pharmaceutical composition
glycine
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201380028968.9A
Other languages
English (en)
Chinese (zh)
Other versions
CN104427982A (zh
Inventor
P·F·特纳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EaglePharma Pty Ltd
Original Assignee
EaglePharma Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2012901301A external-priority patent/AU2012901301A0/en
Application filed by EaglePharma Pty Ltd filed Critical EaglePharma Pty Ltd
Publication of CN104427982A publication Critical patent/CN104427982A/zh
Application granted granted Critical
Publication of CN104427982B publication Critical patent/CN104427982B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CN201380028968.9A 2012-04-02 2013-04-02 治疗炎性和免疫障碍的组合物 Expired - Fee Related CN104427982B (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUAU2012901301 2012-04-02
AU2012901301A AU2012901301A0 (en) 2012-04-02 Treatment of inflammatory and immune disorders
AU2012901301 2012-04-02
PCT/GB2013/050865 WO2013150292A1 (en) 2012-04-02 2013-04-02 Composition for the treatment of inflammatory and immune disorders

Publications (2)

Publication Number Publication Date
CN104427982A CN104427982A (zh) 2015-03-18
CN104427982B true CN104427982B (zh) 2017-05-17

Family

ID=48184233

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380028968.9A Expired - Fee Related CN104427982B (zh) 2012-04-02 2013-04-02 治疗炎性和免疫障碍的组合物

Country Status (8)

Country Link
US (1) US9387218B2 (enExample)
EP (1) EP2836208B1 (enExample)
JP (1) JP6188784B2 (enExample)
CN (1) CN104427982B (enExample)
AU (1) AU2013203825B2 (enExample)
CA (1) CA2869243C (enExample)
MX (1) MX355103B (enExample)
WO (1) WO2013150292A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018051154A1 (en) * 2016-09-15 2018-03-22 Perscellmed Roth & Partner Compound of zinc salicylate and sulphur combination as a novel treatment for asthma and copd

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1917869A (zh) * 2004-02-09 2007-02-21 希尔氏宠物营养品公司 用于软骨感染病症的组合物和方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4514421A (en) 1979-08-30 1985-04-30 Herschler R J Dietary and pharmaceutical uses of methylsulfonylmethane and compositions comprising it
US20030069202A1 (en) * 2000-06-02 2003-04-10 Kern Kenneth Norman Compositions, kits, and methods for promoting defined health benefits
US6902739B2 (en) * 2001-07-23 2005-06-07 Nutracea Methods for treating joint inflammation, pain, and loss of mobility
US6841173B2 (en) * 2002-03-26 2005-01-11 Peter L. Reynolds Compositions and methods directed towards sore muscles and joints
US20060251750A1 (en) * 2002-09-30 2006-11-09 Tabor Aaron T Soy formulations and their use in skin care
JP2005013124A (ja) * 2003-06-27 2005-01-20 Toyo Shinyaku:Kk 美容効果を有する食品組成物
US20060029647A1 (en) 2004-02-09 2006-02-09 Friesen Kim G Composition and method for use in cartilage affecting conditions
US20070020218A1 (en) * 2005-07-21 2007-01-25 Eileen Richardson Composition and method for the treatment of psoriasis
US7335384B2 (en) * 2006-03-17 2008-02-26 4K Nutripharma International Nutrient compositions for the treatment and prevention of inflammation and disorders associated therewith
US20090110674A1 (en) * 2007-10-24 2009-04-30 Loizou Nicos C Health supplement
US20130281401A1 (en) 2010-10-07 2013-10-24 Eaglepharma Pty Ltd Combination therapy for the treatment of depression and other non-infectious diseases

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1917869A (zh) * 2004-02-09 2007-02-21 希尔氏宠物营养品公司 用于软骨感染病症的组合物和方法

Also Published As

Publication number Publication date
MX2014011922A (es) 2015-12-03
MX355103B (es) 2018-04-05
CA2869243A1 (en) 2013-10-10
JP6188784B2 (ja) 2017-08-30
US20150111850A1 (en) 2015-04-23
JP2015512439A (ja) 2015-04-27
AU2013203825B2 (en) 2015-12-17
WO2013150292A1 (en) 2013-10-10
HK1207293A1 (en) 2016-01-29
AU2013203825A1 (en) 2013-10-17
CN104427982A (zh) 2015-03-18
EP2836208A1 (en) 2015-02-18
EP2836208B1 (en) 2019-09-25
CA2869243C (en) 2021-03-16
US9387218B2 (en) 2016-07-12

Similar Documents

Publication Publication Date Title
US11084813B2 (en) High penetration drugs and their compositions thereof for treatment of Parkinson diseases
EP3388417A1 (en) Positively charged water-soluble prodrugs of acetaminophen and related compounds with very fast skin penetration rate
JP2019142907A (ja) トレハロースの非経口投与によるタンパク質凝集ミオパシーおよび神経変性疾患の治療
JPH03181422A (ja) 炎症の治療方法及び炎症の治療用合成薬
CN116265017A (zh) 一种包含本维莫德和皮质类固醇的药物组合物
JP5542309B2 (ja) 経口医薬組成物
KR20220035512A (ko) 비강내 에피네프린 제제 및 질환의 치료 방법
WO2019038586A1 (en) PHARMACEUTICAL COMPOSITION OF MELATONIN
CN104427982B (zh) 治疗炎性和免疫障碍的组合物
FI4199922T3 (fi) (1r,3s)-3-((5-syano-4-fenyylitiatsol-2-yyli)karbamoyyli)syklopentaani-1-karboksyylihappo käytettäväksi hengitystietautien hoidossa
ES2248131T3 (es) Combinacion de loteprednol y agonistas de adrenoceptor beta2 y su utilizacion por inhalacion para el tratamiento del asma bronquial.
CN108703946A (zh) 一种治疗糖尿病周围神经痛的透皮吸收制剂
CN100357312C (zh) 赖氨酸七叶皂苷及其制备方法和其用途
KR20130124349A (ko) 〔（（1ｒ,2ｓ,5ｒ）―2―이소프로필―5―메틸―시클로헥산카르보닐）―아미노〕―아세트산 이소프로필 에스테르와 관련 화합물 및 요법에서 그의 용도
US20020198228A1 (en) Composition and method for the treatment of respiratory desease
HK1207293B (en) Composition for the treatment of inflammatory and immune disorders
JP2016504358A (ja) オキシブチニンを投与するための方法および組成物
CN111184706B (zh) 一种防治胆囊炎的活性药物及其用途
JPS58164516A (ja) 湿疹性皮膚疾患および薬疹治療剤
CN100496492C (zh) 治疗慢性鼻窦炎的甲苯咪唑新剂型
CN115137809A (zh) 含有促肾上腺皮质激素及其衍生物的药物及其用途
WO2017114379A1 (zh) 一种治疗多发性硬化症的鼻用凝胶组合物
KR102027176B1 (ko) 〔（（1ｒ,2ｓ,5ｒ）―2―이소프로필―5―메틸―시클로헥산카르보닐）―아미노〕―아세트산 이소프로필 에스테르와 관련 화합물 및 요법에서 그의 용도
CN119925347A (zh) 化合物Pladienolide B作为抗蓖麻毒素保护剂的医药用途
WO2025103426A1 (zh) 白塞综合征的治疗

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20170517